Primer Capital logo

Primer Capital

Helping pharma and biotech projects change the future

Founded 2015 Russia Moscow, Russia 1 employees Biotechnology, Financial Services +1

14

Total Investments

11

Portfolio Companies

-

Exits

3

Industries

General Information

Industries Biotechnology, Financial Services +1

Company Overview

Founded 2015
Employees 1
Location Russia Moscow, Russia

About Primer Capital

PRIMER CAPITAL is a venture capital fund focusing on investments in companies engaged in development of promising biotech and medical products for various pharmaceutical sectors. Our qualified managing Team is interested in a high-quality selection of projects that form our portfolio. Our team of qualified consultants and Scientific Advisory Board consisting of top experts in various medical, biopharmaceutical, and business fields contribute considerably to successful project selection. We cooperate with venture capital funds, business angels, government agencies interested in the development of biopharmaceutical industry, medical institutions and laboratories. Our many years’ experience and in-depth knowledge of the industry ecosystem provides portfolio companies with all opportunities for a quick start and establishment of effective relationships with their key partners throughout the whole period of its growth.

Recent Investments (14)

View All
Company Stage Amount Date
Series A •••••• Oct 2021
Convertible Note •••••• Mar 2021
Series B •••••• Dec 2020
Convertible Note •••••• Sep 2020
Seed Round •••••• Oct 2018
Portfolio company •••• ••••
Grant •••••• Jan 2018
Portfolio company •••• ••••
Series A •••••• Jan 2018
Portfolio company •••• ••••
Venture Round •••••• Nov 2017
Portfolio company •••• ••••
Venture Round •••••• Oct 2017
Portfolio company •••• ••••
Series A •••••• Sep 2017

See all 14 investments →

All startup & investor data, one platform.

Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.

Access Millions of Companies and 50K+ Investors

Signal-based outbound intelligence for sales, agencies, and investors.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes